GT Cef XP 500mg/62.5mg Injection
Marketer
Loremchem Pharmaceutical
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview GT Cef XP 500mg/62.5mg Injection
Cefixime and Sulbactam 500mg/62.5mg Injection is a dual-action antibiotic. This medication is used to combat a range of bacterial infections by inhibiting microbial proliferation and halting infection progression. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is essential, even with symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include, but are not limited to, gastrointestinal upset (nausea, vomiting, diarrhea), and indigestion. Severe or worsening side effects necessitate immediate medical attention. Seek emergency care for allergic responses (skin rash, itching, swelling, breathing difficulties). Inform your physician of all current medications, including those for pre-existing conditions, prior to commencing treatment. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of GT Cef XP 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of GT Cef XP 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of GT Cef XP 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use GT Cef XP 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How GT Cef XP 500mg/62.5mg Injection works:
Ceftriaxone/Tazobactam Injection (GT Cef XP 500mg/62.5mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from co-ingesting alcohol and GT Cef XP 500mg/62.5mg Injection.
PregnancySAFE IF PRESCRIBED
Cefixime/Sulbactam 500mg/62.5mg injection (GT Cef XP) is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Cefixime and Sulbactam injection (GT Cef XP 500mg/62.5mg) requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Cefixime and Sulbactam injection (GT Cef XP 500mg/62.5mg) can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of GT Cef XP 500mg/62.5mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive GT Cef XP 500mg/62.5mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration of GT Cef XP 500mg/62.5mg Injection is not advised for individuals with mild to moderate liver dysfunction.
What if you forget to take GT Cef XP 500mg/62.5mg Injection :
Should you inadvertently omit a dose of GT Cef XP 500mg/62.5mg Injection, seek medical advice from your physician.
Facts to Know About GT Cef XP 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently